Literature DB >> 15713706

Subtle 17alpha-hydroxylase/17,20-lyase deficiency with homozygous Y201N mutation in an infertile woman.

Matsuo Taniyama1, Makito Tanabe, Hiroshi Saito, Yoshio Ban, Hajime Nawata, Toshihiko Yanase.   

Abstract

Steroid 17alpha-hydroxylase deficiency is characterized by failed sexual development and mineralocorticoid hypertension. Female patients usually exhibit primary amenorrhea. Some patients with partial deficiency are reported to have menses, yet they have hypertension and hypokalemia. We describe here a normotensive, infertile female patient with menses and minimal defects in secondary sex characteristics. The patient experienced menarche at age 13, and her menstrual cycles were regular until age 18 and irregular thereafter. Pubic hair was present (Tanner stage 3), and breast maturation was within normal range (Tanner stage 5). The patient's resting blood pressure was normal, and hypokalemia was not observed despite high blood corticosterone levels and reduced plasma renin activity. Analysis of the CYP17 gene revealed that the patient was homozygous for the Y201N mutation. In vitro expression of the mutated Y201N enzyme revealed reduced activities of both 17alpha-hydroxylase and 17,20-lyase; however, these reductions were less than those of the F53/54DEL mutation, which also shows mild clinical deficiency of 17alpha-hydroxylase/17,20-lyase. Thus, the 17alpha-hydroxylase/17,20-lyase deficiency in the present case is very mild both clinically and enzymatically. This case raises the possibility that there are infertile, menstruating women with undiagnosed 17alpha-hydroxylase deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713706     DOI: 10.1210/jc.2004-2067

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

Review 1.  Defects of steroidogenesis.

Authors:  A Biason-Lauber; M Boscaro; F Mantero; G Balercia
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

2.  How Is CYP17A1 Activity Altered in Autism? A Pilot Study to Identify Potential Pharmacological Targets.

Authors:  Benedikt Andreas Gasser; Johann Kurz; Bernhard Dick; Markus Georg Mohaupt
Journal:  Life (Basel)       Date:  2022-06-10

3.  The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series.

Authors:  Min Sun; Jonathan W Mueller; Lorna C Gilligan; Angela E Taylor; Fozia Shaheen; Anna Noczyńska; Guy T'Sjoen; Louise Denvir; Savitha Shenoy; Piers Fulton; Timothy D Cheetham; Helena Gleeson; Mushtaqur Rahman; Nils P Krone; Norman F Taylor; Cedric H L Shackleton; Wiebke Arlt; Jan Idkowiak
Journal:  Eur J Endocrinol       Date:  2021-10-11       Impact factor: 6.664

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.